Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez‐Esteban… - Cochrane database …, 2005 - cochranelibrary.com
Background Metformin is an anti‐hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long‐term complications: micro‐(retinopathy …
diabetes mellitus. Type 2 diabetes may present long‐term complications: micro‐(retinopathy …
[引用][C] Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez‐Esteban… - Cochrane Database …, 1996 - cochranelibrary.com
Background Metformin is an anti‐hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long‐term complications: micro‐(retinopathy …
diabetes mellitus. Type 2 diabetes may present long‐term complications: micro‐(retinopathy …
Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez-Esteban… - The Cochrane …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Metformin is an anti-hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
Metformin monotherapy for type 2 diabetes mellitus.
A Saenz, I Fernandez-Esteban, A Mataix… - The Cochrane …, 2005 - europepmc.org
Background Metformin is an anti-hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez-Esteban, A Mataix… - Cochrane Database of …, 2005 - hero.epa.gov
Background Metformin is an anti-hyperglycaemic agent used for the treatment of type 2
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
diabetes mellitus. Type 2 diabetes may present long-term complications: micro-(retinopathy …
[引用][C] Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez-Esteban, A Mataix… - Cochrane Database of …, 2005 - cir.nii.ac.jp
Metformin monotherapy for type 2 diabetes mellitus | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[引用][C] WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
A Saenz, I Fernandez-Esteban, A Mataix… - … Cochrane Database of …, 2015 - europepmc.org
WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
[引用][C] WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez-Esteban… - The Cochrane …, 2015 - pubmed.ncbi.nlm.nih.gov
WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus WITHDRAWN:
Metformin monotherapy for type 2 diabetes mellitus Cochrane Database Syst Rev. 2015 …
Metformin monotherapy for type 2 diabetes mellitus Cochrane Database Syst Rev. 2015 …
[引用][C] Metformin monotherapy for type 2 diabetes mellitus
A SAENZ - Cochrane Database Syst Rev, 2005 - cir.nii.ac.jp
[引用][C] WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus
A Saenz, I Fernandez-Esteban, A Mataix… - Cochrane Database of …, 2015 - hero.epa.gov
WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus | Health & Environmental
Research Online (HERO) | US EPA Jump to main content US EPA United States …
Research Online (HERO) | US EPA Jump to main content US EPA United States …